JPRN-UMIN000011890
Recruiting
N/A
A pilot study to evaluate the efficacy of lafutidine in patients with paclitaxel-induced peripheral neuropathy. - A pilot study to evaluate the efficacy of lafutidine in patients with paclitaxel-induced peripheral neuropathy.
Fukushima medical University Hospital, School of medicine0 sites30 target enrollmentSeptember 27, 2013
Conditionsgynecological cancer
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- gynecological cancer
- Sponsor
- Fukushima medical University Hospital, School of medicine
- Enrollment
- 30
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •(1\) Current use of other anti\-ulcer drugs. (2\) Pregnant females and nursing mothers. (3\) With history of severe drug allergies. (4\) Physician concludes that the patient's participation in this trial is inappropriate.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not Yet Recruiting
Phase 3
A pilot study to assess the efficiency of Lamivudine, a drug used to treat HIV, in retinal edema due to vein occlusioHealth Condition 1: H348- Other retinal vascular occlusionsCTRI/2024/04/065756Aravind Eye Hospital
Completed
Phase 2
Random Phase II Study of Effectiveness of Laftidine and Pregabalin for Paclitacel-Induced Peripheral Neuropathy in the Patients with Gynecologic MalignancyPaclitaxel-induced peripheral neuropathy in the patients with gynecological malignanciesJPRN-UMIN000010688Kansai Clinical Oncology Group80
Completed
Phase 3
Clinical trial on the effectiveness of the Famotidine on symptoms of schizophrenic patientsIRCT20190707044123N1Rasht University of Medical Sciences64
Active, Not Recruiting
N/A
Etude prospective ouverte de l'efficacité du leflunomide dans le traitement de la pemphigoïde bulleuse en association aux dermocorticoïdes. - ARABPemphigoïde bulleuseMedDRA version: 9.1Level: LLTClassification code 10006567Term: Bullous pemphigoidEUCTR2007-003545-32-FRCHU de Limoges
Active, Not Recruiting
N/A
The effect of ALFALIFE™ in reducing low-grade inflammatioow-grade inflammationNutritional, Metabolic, EndocrineChronic low-grade inflammationISRCTN12319920Digitcal S.r.l.24